about
Comparison of minichromosome maintenance proteins (MCM-3, MCM-7) and metallothioneins (MT-I/II, MT-III) expression in relation to clinicopathological data in ovarian cancer.Effects of synergistic massage and physical exercise on the expression of angiogenic markers in rat tendons.Expression of the MT1 melatonin receptor in ovarian cancer cells.Myocarditis in dogs: etiology, clinical and histopathological features (11 cases: 2007-2013)Prolactin-induced protein as a potential therapy response marker of adjuvant chemotherapy in breast cancer patients.Expression of metallothionein 3 in ductal breast cancer.The role of YKL-40 in a cancerous process.The Impact of Melatonin on Colon Cancer Cells' Resistance to Doxorubicin in an in Vitro Study.Nogo-B expression, in arterial intima, is impeded in the early stages of atherosclerosis in humans.Melatonin Synergizes the Chemotherapeutic Effect of Cisplatin in Ovarian Cancer Cells Independently of MT1 Melatonin Receptors.Massage may initiate tendon structural changes--a preliminary study.Role of PD-L1 Expression in Non-Small Cell Lung Cancer and Their Prognostic Significance according to Clinicopathological Factors and Diagnostic MarkersIncreased skeletal muscle expression of VEGF induced by massage and exerciseArterial wall lymphangiogenesis is increased in the human iliac atherosclerotic arteries: involvement of CCR7 receptorThe Role of CHI3L1 Expression in Angiogenesis in Invasive Ductal Breast CarcinomaProlactin-induced protein (PIP)-characterization and role in breast cancer progressionExpression of Irisin/FNDC5 in Cancer Cells and Stromal Fibroblasts of Non-small Cell Lung CancerPrognostic Impact of Melatonin Receptors MT1 and MT2 in Non-Small Cell Lung Cancer (NSCLC)MCM5 Expression Is Associated With the Grade of Malignancy and Ki-67 Antigen in LSCCCorrelation of Expression of CHI3L1 and Nogo-A and their Role in Angiogenesis in Invasive Ductal Breast CarcinomaTranscriptomic Alterations of the Aortic Intima and Media in Long-term High-fat Diet Fed Pigs and Its Reversal (P15-010-19)
P50
Q30712230-030B68AB-BD4B-4AB8-9542-7C84A91897DFQ33679182-69EFF62B-529C-47CE-8E7A-C4D33F77A826Q34835245-F438C925-0137-49BF-A860-11E51C72613DQ35030201-501D3A67-2305-46F3-9B48-6CACA59C1ADCQ36958351-168FED82-4717-4E6C-8AA0-7EDAA87890C1Q38731339-F44F3D90-EF8D-4BAF-B146-E98B8BA79518Q39057987-DA629C19-5B43-479F-8FEF-2B1F65126A8BQ41181680-2075D450-631F-4E71-BDC7-CCADF42C6FE3Q46133664-FDAA66B8-45F1-4E8A-A98D-CB960799114CQ47169877-9CC829D3-5C8D-4E2D-A57C-27CC13DD346CQ53505862-AC7E2307-A04A-4896-85CE-D5AE90A3380AQ64260223-F95738C3-EED7-4B06-A6D5-227C2EA8C6EAQ85546494-639B6341-2720-49F1-B4DA-20BAA8C27B44Q85795861-C554C2BD-BD6F-4622-A1E7-F1BCE72FD63DQ88923599-03525269-A2AE-46C4-99F9-2642C746FE25Q90573145-5FA5B169-F49F-4DEE-99AD-9C9E6D03DDD6Q90721811-84A3B7F4-D326-4AEC-9674-68729BD3004CQ91994960-F5BDA09C-DCD7-47D5-A926-FD883C82AA3CQ92048623-46B660AC-C970-49AC-96A8-551B5D3492F7Q92048637-B20E8FC7-C6A1-4A5A-A8E6-0A898D8BED71Q94494522-70FB190F-8A2A-4201-ADB3-1C7D99BCE437
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Karolina Jablonska
@en
Karolina Jablonska
@nl
type
label
Karolina Jablonska
@en
Karolina Jablonska
@nl
prefLabel
Karolina Jablonska
@en
Karolina Jablonska
@nl
P31
P496
0000-0002-7989-3264